Sanofi-Aventis (France) Suspends Acomplia Sales in Europe

Published: Oct 23, 2008

PARIS-French pharmaceutical company Sanofi-Aventis temporarily suspended sales of anti-obesity drug Acomplia in Europe, the company said Thursday, after health authorities said the drug's risks outweigh its benefits.

Back to news